17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Evaluating Face2Gene as a Tool to Identify Cornelia de Lange Syndrome by Facial Phenotypes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Characteristic or classic phenotype of Cornelia de Lange syndrome (CdLS) is associated with a recognisable facial pattern. However, the heterogeneity in causal genes and the presence of overlapping syndromes have made it increasingly difficult to diagnose only by clinical features. DeepGestalt technology, and its app Face2Gene, is having a growing impact on the diagnosis and management of genetic diseases by analysing the features of affected individuals. Here, we performed a phenotypic study on a cohort of 49 individuals harbouring causative variants in known CdLS genes in order to evaluate Face2Gene utility and sensitivity in the clinical diagnosis of CdLS. Based on the profile images of patients, a diagnosis of CdLS was within the top five predicted syndromes for 97.9% of our cases and even listed as first prediction for 83.7%. The age of patients did not seem to affect the prediction accuracy, whereas our results indicate a correlation between the clinical score and affected genes. Furthermore, each gene presents a different pattern recognition that may be used to develop new neural networks with the goal of separating different genetic subtypes in CdLS. Overall, we conclude that computer-assisted image analysis based on deep learning could support the clinical diagnosis of CdLS.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources

          Abstract The Human Phenotype Ontology (HPO)—a standardized vocabulary of phenotypic abnormalities associated with 7000+ diseases—is used by thousands of researchers, clinicians, informaticians and electronic health record systems around the world. Its detailed descriptions of clinical abnormalities and computable disease definitions have made HPO the de facto standard for deep phenotyping in the field of rare disease. The HPO’s interoperability with other ontologies has enabled it to be used to improve diagnostic accuracy by incorporating model organism data. It also plays a key role in the popular Exomiser tool, which identifies potential disease-causing variants from whole-exome or whole-genome sequencing data. Since the HPO was first introduced in 2008, its users have become both more numerous and more diverse. To meet these emerging needs, the project has added new content, language translations, mappings and computational tooling, as well as integrations with external community data. The HPO continues to collaborate with clinical adopters to improve specific areas of the ontology and extend standardized disease descriptions. The newly redesigned HPO website (www.human-phenotype-ontology.org) simplifies browsing terms and exploring clinical features, diseases, and human genes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement

            Cornelia de Lange syndrome (CdLS) is an archetypical genetic syndrome that is characterized by intellectual disability, well-defined facial features, upper limb anomalies and atypical growth, among numerous other signs and symptoms. It is caused by variants in any one of seven genes, all of which have a structural or regulatory function in the cohesin complex. Although recent advances in next-generation sequencing have improved molecular diagnostics, marked heterogeneity exists in clinical and molecular diagnostic approaches and care practices worldwide. Here, we outline a series of recommendations that document the consensus of a group of international experts on clinical diagnostic criteria, both for classic CdLS and non-classic CdLS phenotypes, molecular investigations, long-term management and care planning.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cohesin: functions beyond sister chromatid cohesion.

              Faithful segregation of chromosomes during mitosis and meiosis is the cornerstone process of life. Cohesin, a multi-protein complex conserved from yeast to human, plays a crucial role in this process by keeping the sister chromatids together from S-phase to anaphase onset during mitosis and meiosis. Technological advancements have discovered myriad functions of cohesin beyond its role in sister chromatid cohesion (SCC), such as transcription regulation, DNA repair, chromosome condensation, homolog pairing, monoorientation of sister kinetochore, etc. Here, we have focused on such functions of cohesin that are either independent of or dependent on its canonical role of sister chromatid cohesion. At the end, human diseases associated with malfunctioning of cohesin, albeit with mostly unperturbed sister chromatid cohesion, have been discussed. Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                04 February 2020
                February 2020
                : 21
                : 3
                : 1042
                Affiliations
                [1 ]Unit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, University of Zaragoza, CIBERER-GCV02 and ISS-Aragon, E-50009 Zaragoza, Spain; alatorre@ 123456unizar.es (A.L.-P.); martage.sc@ 123456gmail.com (M.G.-S.); marnedo@ 123456unizar.es (M.A.); cristinaluca96@ 123456hotmail.com (C.L.-C.); rebecantop@ 123456gmail.com (R.A.-P.); puisac@ 123456unizar.es (B.P.); framos@ 123456unizar.es (F.J.R.)
                [2 ]Department of Paediatrics, Hospital Clínico Universitario “Lozano Blesa”, E-50009 Zaragoza, Spain; angelaascaso@ 123456hotmail.com (Á.A.); lautrujillano@ 123456gmail.com (L.T.);
                [3 ]Molecular Modelling Group, Centro de Biología Molecular Severo Ochoa, CBMSO (CSIC-UAM), E-28049 Madrid, Spain; imarcos@ 123456cbm.csic.es
                [4 ]Bioscience Research Institute, School of Experimental Sciences, Universidad Francisco de Vitoria, UFV, E-28223 Pozuelo de Alarcón, Spain
                [5 ]Section for Functional Genetics, Institute of Human Genetics, University of Lübeck, 23562 Lübeck, Germany; ilaria.parenti@ 123456ist.ac.at (I.P.); frank.kaiser@ 123456uk-essen.de (F.J.K.)
                [6 ]Institute of Science and Technology (IST) Austria, 3400 Klosterneuburg, Austria
                [7 ]Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, I-56124 Pisa, Italy; antonio.musio@ 123456irgb.cnr.it
                [8 ]Institute for Human Genetics, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany
                Author notes
                [* ]Correspondence: juanpie@ 123456unizar.es (J.P.); pagomez@ 123456cbm.csic.es (P.G.-P.); Tel.: +34-976-761677 (J.P.); +34-91-1964663 (P.G.-P.)
                Author information
                https://orcid.org/0000-0002-4703-6620
                https://orcid.org/0000-0001-9962-2157
                https://orcid.org/0000-0002-0674-6423
                https://orcid.org/0000-0001-7701-6543
                https://orcid.org/0000-0003-3203-6254
                Article
                ijms-21-01042
                10.3390/ijms21031042
                7038094
                32033219
                c05e4512-93fa-4c53-8781-4901b1325fc9
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 30 December 2019
                : 02 February 2020
                Categories
                Article

                Molecular biology
                cornelia de lange syndrome,face2gene,facial recognition,deep learning
                Molecular biology
                cornelia de lange syndrome, face2gene, facial recognition, deep learning

                Comments

                Comment on this article